Unique patients, n |
267 |
Sex, n (%) |
Female |
196 (73.4) |
Male |
71 (26.6) |
Age at date of first electronic prescription, mean (SD), y |
51.5 (14.1) |
Age range (minimum–maximum), y |
20–97 |
Age range breakdown, n (%), y |
18–34 |
34 (12.7) |
35–49 |
78 (29.2) |
50–64 |
118 (44.2) |
≥65 |
37 (13.9) |
No. of unique electronic prescriptions |
557 |
Prescription breakdown, no. (%) |
Citalopram |
63 (11.3) |
Duloxetine |
113 (20.3) |
Sertraline |
209 (37.5) |
Venlafaxine |
172 (30.9) |
Prescription breakdown by class, no. (%) |
Serotonin-norepinephrine reuptake inhibitor |
272 (48.8) |
Selective serotonin reuptake inhibitor |
285 (51.2) |
Prescription breakdown by sex, no. (%) |
Female |
412 (74.0) |
Male |
145 (26.0) |
Previous therapy (within 1 y prior to date of electronic prescription), no. (%) |
New to all antidepressants |
55 (9.9) |
Another antidepressant only |
27 (4.8) |
Electronically prescribed antidepressant |
475 (85.3) |
Type of health plan, no. (%) |
Health management organization |
217 (39.0) |
Preferred provider organization |
204 (36.6) |
Medicare Part D |
72 (12.9) |
Indemnity |
64 (11.5) |
Type of prescriber, no. (%) |
Primary care |
428 (76.8) |
Psychiatrist |
44 (7.9) |
Other |
85 (15.3) |